This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Charbonneau, M.-E.
Right arrow Articles by Mourez, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Charbonneau, M.-E.
Right arrow Articles by Mourez, M.

 Previous Article  |  Next Article 

Journal of Bacteriology, December 2007, p. 9020-9029, Vol. 189, No. 24
0021-9193/07/$08.00+0     doi:10.1128/JB.01238-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Functional Organization of the Autotransporter Adhesin Involved in Diffuse Adherence{triangledown} ,{dagger}

Marie-Ève Charbonneau and Michael Mourez*

Canada Research Chair on Bacterial Animal Diseases, Université de Montréal, Faculté de Médecine Vétérinaire, Saint-Hyacinthe, Québec, Canada

Received 31 July 2007/ Accepted 2 October 2007


arrow
ABSTRACT
 
The Escherichia coli adhesin involved in diffuse adherence (AIDA-I) is a multifunctional autotransporter protein that mediates bacterial aggregation and biofilm formation, as well as adhesion and invasion of cultured epithelial cells. To elucidate the structure-function relationships of AIDA-I, we performed transposon-based linker scanning mutagenesis and constructed mutants with site-directed deletions. Twenty-nine different mutants with insertions that did not affect protein expression were obtained. Eleven mutants were deficient for one or two but not all of the functions associated with the expression of AIDA-I. Functional characterization of the transposon mutants and of an additional deletion mutant suggested that the N-terminal third of mature AIDA-I is involved in binding of this protein to cultured epithelial cells. The purified product of the putative domain could bind to cultured epithelial cells, confirming the importance of this region in adhesion. We also identified several different mutants in which invasion and adhesion were changed to different extents and two mutants in which autoaggregation and biofilm formation were also affected differently. These results suggest that although conceptually linked, adhesion and invasion, as well as autoaggregation and biofilm formation, are phenomena that may rely on distinct mechanisms when they are mediated by AIDA-I. This study sheds new light on the workings of a protein belonging to an emerging family of strikingly versatile virulence factors.


arrow
INTRODUCTION
 
Diarrhea-causing strains of Escherichia coli are responsible for many cases of gastrointestinal disease (14). Diffusely adhering E. coli (DAEC) is one of the six classes of E. coli that have been associated with diarrhea. This group is characterized by a pattern of diffuse adherence on the surface of epithelial cells (23, 29). DAEC strains have been identified based on their diffuse adherence on cultured epithelial cells, and they appear to form a heterogeneous group. The first class of DAEC strains includes E. coli strains that harbor Afa/Dr adhesins, which are proteins that have been found to be associated with urinary tract infections and with enteric infections in infants (30). The second class of DAEC strains includes E. coli strains that express an adhesin involved in diffuse adherence (AIDA-I) (2). AIDA-I was originally identified in strain 2787 isolated from a patient with infantile diarrhea. AIDA-I has also been found in E. coli strains causing edema disease and postweaning diarrhea in piglets, two major causes of economic losses on farms worldwide (21, 24, 25).

AIDA-I belongs to the family of monomeric autotransporter proteins, a branch of the type V secretion pathway (11). Most autotransporter proteins identified so far are proven or predicted virulence factors (10). AIDA-I is synthesized as a preproprotein with a molecular mass of approximately 145 kDa and has a modular organization, like all autotransporters (1). The N terminus of the preproprotein corresponds to a sec-dependent sequence signal consisting of 49 amino acids. Cleavage of the sequence signal results in release of the proprotein in the periplasm. The proprotein comprises two different domains (34): the 100-kDa surface-exposed mature AIDA-I protein and a 45-kDa membrane-embedded domain, AIDAc. The latter is believed to form a pore in the outer membrane which may serve as the translocation conduit for mature AIDA-I towards the cell surface. Mature AIDA-I is cleaved after secretion, presumably by an autocatalytic event (34), but it remains strongly associated with AIDAc (1, 4).

Recently, AIDA-I has been proposed to be a member of a new group of autotransporter proteins called self-associating autotransporters (SAATs) (16). This group also includes Ag43, a surface protein widely distributed among pathogenic and nonpathogenic strains of E. coli and responsible for bacterial aggregation (27), and TibA, an adhesin/invasin of enterotoxigenic E. coli (5). These proteins share sequence similarities, are all glycosylated by specific heptosyltransferases that can be functionally exchanged, and possess the same multiple properties likely to be important for virulence of pathogenic strains: the ability to mediate bacterial aggregation, biofilm formation, and invasion of and adhesion to cultured epithelial cells (3, 9, 20, 22, 31-33). A structure-function study of Ag43 has been performed (15), and it revealed that the domain responsible for the aggregation phenotype resides within the N-terminal 160 residues and is distinct from the domain allowing biofilm formation. Indeed, nonaggregative variants of Ag43 could still mediate attachment to abiotic surfaces. Ag43 can also mediate adhesion to and invasion of epithelial cells (7, 31), but no region related to these phenotypes has been identified so far. In addition, this kind of analysis has never been conducted with AIDA-I or TibA. Therefore, more information is required to better understand the molecular basis of SAAT multifunctionality.

In the present report, we describe a mutagenesis study of AIDA-I. We used random transposon scanning mutagenesis and construction of a domain deletion mutant in order to identify regions in mature AIDA-I involved in the various phenotypes associated with the expression of this protein. Our data revealed that the N-terminal third of the protein is specifically involved in attachment to cultured epithelial cells. We also identified other mutations that affect each of the other functions of AIDA-I. The existence of mutants with mutations that altered invasion but not adhesion and vice versa, as well as a mutant with a mutation that altered autoaggregation but not biofilm formation and vice versa, suggested that these phenomena involve distinct mechanisms. Taken together, our results provide new insights into the mechanism of action of the SAAT group of autotransporters.


arrow
MATERIALS AND METHODS
 
Bacterial strains and plasmids. E. coli K-12 strains C600 (New England Biolabs) (F thr-1 leuB6 thi-1 lacY1 supE44 rfbD1 fhuA21) and BL21 (Stratagene) [F ompT hsdS(rB mB) gal] were used in this study. Plasmids pAngH and pAah, which allow expression of AIDA-I and its specific glycosyltransferase (Aah), respectively, will be described elsewhere (4a). Plasmid pAngH was derived from the pTRC99A vector (Pharmacia Biotech) and is compatible with pAah, a pACYC184-derived plasmid. AIDA-I expressed by pAngH contains a protein tag consisting of six histidine residues and a glycine (HisG) at the N terminus of the proprotein.

To construct five-amino-acid insertion mutants, the pAngH plasmid was randomly mutagenized using the GPS-LS linker scanning system (New England Biolabs) according to the instructions of the manufacturer. The presence of an insertion was assessed by PCR. Plasmids with insertions were transformed in E. coli strain C600. DNA sequencing was used to determine the insertion sequence and its precise location.

The {Delta}N, {Delta}C, {Delta}C2, and {Delta}NC deletions were introduced into pAngH by oligonucleotide-directed mutagenesis performed with a QuikChange II site-directed mutagenesis kit (Stratagene) using the primers listed in Table 1 and the corresponding complementary oligonucleotides, which generated pAngH{Delta}N (deletion of amino acids 54 to 225), pAngH{Delta}C (deletion of amino acids 224 to 637), pAngH{Delta}C2 (deletion of amino acids 224 to 667), and pAngH{Delta}NC (deletion of amino acids 54 to 667). To generate glutathione S-transferase (GST) fused to AIDAN (the N-terminal portion of mature AIDA-I), a fragment of the aidA gene corresponding to amino acids 50 to 224 was amplified by performing PCR with primers that introduced BamHI and XhoI restriction sites (Table 1). The DNA fragment was digested with BamHI and XhoI and cloned at the same sites into the pGex-4T-1 vector (Amersham Biosciences) to create pGex-AIDAN.


View this table:
[in this window]
[in a new window]

 
TABLE 1. Primers used in this study

Bacterial and cell culture growth conditions. Bacteria containing the different plasmids were grown on Luria-Bertani (LB) agar plates or in liquid LB medium containing 100 µg·ml–1 ampicillin and 50 µg·ml–1 chloramphenicol, unless indicated otherwise. Bacterial cultures were grown at 30°C. Growth was monitored by measuring the optical density at 600 nm (OD600). At an OD600 of 0.8, the cultures were induced with 10 µM isopropyl-β-D-thiogalactopyranoside (IPTG), unless indicated otherwise. This low concentration of IPTG was used to limit the toxicity associated with overexpression of AIDA-I. HEp-2 cells (= ATCC CCL-23) were grown at 37°C with 5% CO2 in Dulbecco's modified Eagle's medium (Gibco) containing 10 mM sodium pyruvate (Sigma), 10% bovine growth serum (HyClone), 2.5 µg·ml–1 amphotericin B (Fungizone), and 100 µg·ml–1 penicillin/streptomycin (Gibco).

Heat extraction. Heat extracts were obtained as previously described (4). Briefly, overnight cultures of E. coli C600 bearing appropriate plasmids were normalized to the same OD600 in 10 ml of LB broth. Bacteria were harvested and resuspended in 150 µl of 10 mM sodium phosphate buffer (pH 7). In order to release mature AIDA-I, the samples were heated at 60°C for 20 min. The treated samples were centrifuged for 5 min at 12,000 x g in microcentrifuge tubes. A 10-µl sample from each supernatant was subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and stained with Coomassie blue, as described below.

Whole-cell lysates. Overnight cultures (10 ml) were grown, normalized, and centrifuged for 10 min at 12,000 x g in microcentrifuge tubes, and the pellets were resuspended in 100 µl of phosphate-buffered saline (PBS). All samples were processed by performing SDS-PAGE and immunoblotting as described below.

SDS-PAGE, immunoblotting, and detection of glycans. Protein samples were diluted in 2x SDS-PAGE loading buffer containing β-mercaptoethanol and denatured by heating at 100°C for 10 min. The samples were then separated by SDS-PAGE on 10 or 12% acrylamide gels. The gels were either stained with Coomassie blue or transferred to polyvinylidene fluoride membranes (Millipore). Immunodetection was performed with a serum raised against heat-extracted mature AIDA-I (a generous gift from M. Ngeleka, University of Saskatchewan) diluted 1:10,000 in blocking buffer (5% skim milk, 50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.05% Triton X-100). A goat anti-rabbit horseradish peroxidase (HRP)-conjugated antibody (Sigma) was used as a secondary antibody according to the instructions of the manufacturer. Alternatively, an anti-HisG HRP-coupled antibody (Invitrogen) diluted 1:5,000 in blocking buffer was used for detection of proteins containing the HisG tag. Immune complexes were revealed using a 3,3',5,5'-tetramethylbenzidine solution for membranes (Sigma). Glycosylation was detected using a digoxigenin-hydrazine labeling glycan detection kit (Roche) according to the instructions of the manufacturer.

Protein purification. For purification of GST fusion proteins, 1-liter cultures of BL21 harboring plasmid pGex-4T-1, pGex-AIDAN, or pGex-AIDAN and pAah were grown until the OD600 was 0.4 and induced with 10 µM IPTG for 3 h. Bacteria were harvested, resuspended in 40 ml of Tris-buffered saline (50 mM Tris-HCl [pH 8], 150 mM NaCl) containing lysozyme (final concentration, 0.4 mg·ml–1) and EDTA (pH 8) (final concentration, 10 mM), and lysed with a French press and an ultrasonic processor. The soluble fraction was isolated by 30 min of centrifugation at 16,000 x g.

For AIDA-I purification, 1-liter cultures of C600 harboring plasmids pAngH and pAah were grown until the OD600 was 0.8 and then were induced overnight with 10 µM IPTG. The cells were lysed as described above, and each lysate was centrifuged for 1 h in an ultracentrifuge at 250,000 x g. The membranes were resuspended in Tris-buffered saline containing 1% Triton X-100, incubated for 1 h, and centrifuged again. The solubilized membranes contained histidine-tagged native AIDA-I.

The proteins were purified using an ÄKTA purifier system with a 5-ml glutathione Sepharose column or with a 1-ml His Trap HP column (Amersham Biosciences) according to the instructions of the manufacturer. The purity of the purified proteins was confirmed by SDS-PAGE and staining with Coomassie blue.

Functional assays. Autoaggregation, biofilm formation, adhesion, and invasion assays were performed as previously described (4). In the autoaggregation assay, cultures of E. coli C600 harboring the pTRC99A vector, plasmids pAah and pAngH, or plasmid pAah and plasmid pAngH bearing a mutation were normalized in 10 ml of LB to an OD600 of approximately 1.5 in culture tubes and left to stand at 4°C. Samples (200 µl) were taken 1 cm below the surface at the beginning of the assay and after 180 min, and the OD600 of the samples were measured. In the biofilm formation assay, normalized cultures of C600 were grown in M9 minimal medium for 24 h at 30°C in plastic microtiter plates. Biofilms were stained with crystal violet. The fixed dye was solubilized with a mixture of ethanol and acetone (80:20), and the absorption at 595 nm of the solution was measured. In the adhesion and invasion assays, cultures of C600 were inoculated onto monolayers of confluent HEp-2 cells in a 24-well plate (approximately 2.5 x 105 cells) using 106 CFU per well. After 3 h, the cells were washed with PBS, and the adhering bacteria were recovered, plated, and counted. In the invasion assay, fresh medium containing gentamicin, penicillin, and streptomycin was added after the 3 h, and the preparations were incubated for an additional 2 h before plating. For 1 x106 CFU (total number) of bacteria expressing wild-type AIDA-I, the maximum level of adhesion was 7.9 x104 CFU and the maximum level of invasion was 2.3 x102 CFU.

All functional assays were performed at least three times in duplicate or triplicate. For each assay, the means of the results obtained with each mutant were compared to the mean obtained with the wild-type control by performing an analysis of variance and Dunnet posttests using the Prism 4.0 software (Graphpad Software).

Cell-based ELISA. HEp-2 cells were grown to confluence in a 96-well plate and fixed for 15 min with PBS containing 2.5% paraformaldehyde and 0.2% glutaraldehyde. After one wash with PBS, the plate was blocked with 3% bovine serum albumin in PBS for 2 h at 37°C. Native glycosylated AIDA-I, GST, unglycosylated GST-AIDAN, and glycosylated GST-AIDAN fusion proteins were added to the cells at concentrations ranging from 300 pM to 1 µM and incubated overnight at 4°C. After extensive washes with PBS, bound proteins were detected with an HRP-coupled antibody raised against GST or against native AIDA-I diluted 1:10,000 in PBS (Amersham Biosciences). Immune complexes were revealed using a 3,3',5,5'-tetramethylbenzidine solution in an enzyme-linked immunosorbent assay (ELISA) (Sigma). The background value was subtracted, and the absorption intensities were normalized by dividing the absorption of each well by the maximal intensity measured on the plate. Experiments were conducted in duplicate at least twice. Binding curves and dissociation constants were obtained by nonlinear regression fitting to a one-binding-site hyperbola curve, using Prism 4.0 (Graphpad Software).

Immunofluorescence microscopy. HEp-2 cells were grown to confluence in a Lab-Tek II chamber slide (Nalge Nunc International). After one wash with PBS, proteins (GST, unglycosylated GST-AIDAN, or glycosylated GST-AIDAN) were added to the cells at a concentration of 1 µM and incubated at 37°C for 1 h. After four washes with PBS, the cells were fixed for 15 min with PBS containing 2.5% paraformaldehyde and 0.2% glutaraldehyde, and the plate was blocked with 3% bovine serum albumin in PBS for 1 h at 37°C. Bound proteins were detected with an antibody raised against GST diluted 1:1,000 in PBS-2% bovine serum albumin. Immune complexes were revealed by incubation with a donkey anti-goat immunoglobulin G-rhodamine red conjugate and examination of the microscopic slides with a fluorescence and phase-contrast Leica DMI4000B microscope (Meyer Instruments).


arrow
RESULTS
 
Generation of five-amino-acid insertions in AIDA-I. For analysis of mature AIDA-I, we used a Tn7-derived transposon system that resulted in five-amino acid insertions in the protein. The mutagenesis was performed with plasmid pAngH, which allows expression of AIDA-I under the control of an IPTG-inducible promoter. In addition, AIDA-I expressed by this construct bears a HisG tag located at the N-terminal end of the proprotein. The tag did not affect the expression of AIDA-I, and bacteria expressing the tagged protein had adhesion, invasion, biofilm formation, and autoaggregation activities identical to those of bacteria expressing the wild-type untagged protein (data not shown). Glycosylation of the protein is important to ensure the normal conformation of the protein and, as a consequence, for the cell-binding properties of AIDA-I (3, 4a). We therefore used plasmid pAah, which allowed expression of Aah, the glycosyltransferase that modifies AIDA-I (3). Plasmids pAngH and pAah carry compatible origins of replication and were introduced into E. coli strain C600.

The mutagenesis procedure yielded 60 different insertions distributed throughout mature AIDA-I. Twenty-nine of these insertions did not affect protein expression, as assessed by immunoblotting of whole-cell lysates with an antibody against the HisG tag (data not shown). The insertion sites and the inserted sequences in these mutants are shown in Table S1 in the supplemental material. The remaining 31 insertions, which disrupted protein expression, were discarded. One reason for discarding these insertions is that the mutagenesis procedure left a PmeI restriction site whose translation resulted in a TAA stop codon in two of the six possible frames. Many of the insertions that resulted in a lack of protein expression were probably due to this introduction of a stop codon and therefore would not have been informative. Alternatively, some of the insertion mutations could have resulted in an unstable protein.

As described below, the function of 11 of the 29 insertion mutants was affected. We examined in greater detail the expression of these mutants, as well as a mutant that was not affected by the insertion (I8) as a control. As shown in Fig. 1, the 100-kDa mature AIDA-I was observed in whole-cell lysates of all mutant bacteria, and it was correctly located at the cell surface, as shown by the release of mature AIDA-I in the supernatant after brief heating at 60°C (1). Moreover, mature AIDA-I of all the mutants appeared at a molecular weight that represented the glycosylated form of the protein, and it could be detected with the anti-AIDA-I antiserum, which recognizes only the glycosylated protein (3). Based on these observations, we concluded that all of the insertion mutants expressed glycosylated AIDA-I, although it was still possible that the extent of glycosylation might have been slightly different in different mutants. This is in agreement with our recent finding that glycosylation is highly heterogeneous and occurs at many sites throughout AIDA-I (4a). These results therefore suggest that the insertions did not affect biogenesis, including the glycosylation status, or the structure of AIDA-I; in other words, these results suggest that these sites are structurally permissive for insertions. For the I2 and I20 mutants, however, two distinct additional bands in the whole-cell lysates reacted with the antibody against mature AIDA-I or against the HisG tag (Fig. 1A and B). These two polypeptides could also be released in the culture supernatant after brief heat treatment (Fig. 1C). N-terminal sequencing was used to identify the cleavage sites. Cleavage of both mutant proteins occurred at the transposon insertion site, between a lysine and a histidine (see Table S1 in the supplemental material). Since the additional cleavage sites were introduced by the inserted sequences and the proteins were only partially processed, we concluded that the structural integrity of these proteins was most likely not affected dramatically.


Figure 1
View larger version (48K):
[in this window]
[in a new window]

 
FIG. 1. Effect of insertions on the expression of AIDA-I. Whole-cell lysates were obtained from overnight cultures of C600 harboring an empty vector (lane –), plasmid pAngH (lane WT), or one of the plasmids bearing a five-amino-acid insertion in pAngH. Bacteria harboring pAngH plasmids also contained the pAah plasmid, which allowed production of the AIDA-I-specific glycosyltransferase, Aah. Proteins separated by SDS-PAGE were probed by immunoblotting with an antiserum against mature AIDA-I (A) or with an antibody against the HisG tag (B) which allowed detection of the proprotein (Pro.) (132 kDa) and mature AIDA-I (100 kDa). (C) Cultures of strain C600 harboring the same plasmids were heat extracted at 60°C for 20 min. The heat extracts were resolved by SDS-PAGE and stained with Coomassie blue. The asterisks indicate additional cleavage sites in AIDA-I resulting from the inserted sequence (see text for details). MW, molecular mass.

Effect of the insertions on AIDA-I. To determine the effects of the insertions on the functionality of the protein, the activity of each mutant was tested using four distinct functional assays: autoaggregation, biofilm formation, adhesion, and invasion assays. Figure 2 shows the results for all the mutants with a deficiency in one or more functions. The mutant I8 protein, which was as functional as the wild-type protein, was included as a control, and the results obtained for this mutant are shown in Fig. 2. The other mutants, for which results are not shown, were as functional in all assays as the wild-type protein.


Figure 2
View larger version (34K):
[in this window]
[in a new window]

 
FIG. 2. Effect of insertion mutants on the functionality of AIDA-I. Bacteria bearing an empty vector (bars –) or expressing wild-type (bars WT) or mutated AIDA-I proteins were tested for the presence of several phenotypes. (A) Autoaggregation assay. Cultures were left standing at 4°C, and the OD600 at the top of the culture was measured at the beginning of the assay (light gray bars) and after 180 min (dark gray bars). (B) Biofilm formation assay. Biofilms formed in microtiter plates were stained with crystal violet, and the amount of fixed dye was measured by determining the absorption at 595 nm. (C) Adhesion and invasion assays. Bacteria that adhered to HEp-2 cells were directly plated and counted. The number of intracellular bacteria was estimated by assessing the resistance to external antibiotics. The data are the percentages of adhesion or invasion compared to bacteria expressing wild-type AIDA-I. Significant differences (P < 0.05) are indicated by asterisks for aggregation and biofilm formation (A and B) and by open circles for adhesion and filled circles for invasion (C). The difference in biofilm formation mediated by I4 was not statistically significant (NS).

Eleven of the 29 insertions caused a defect in one or more functions associated with the expression of AIDA-I. The positions of the insertions, as well as the results of the functional characterization analyses, are summarized in Fig. 3. The mutations in I1, I2, I4, I5, and I6, all located in the N-terminal third of mature AIDA-I, caused a defect in adhesion. As a consequence, most of these mutations caused a defect in the ability to invade cultured epithelial cells. The only exception was mutant I4; the results for this mutant were not statistically different from the results for the wild type (Fig. 2C). These results suggest that the N-terminal region of mature AIDA-I is involved in adhesion. Three other insertions in the C-terminal half of the protein (mutants I20, I23, and I24) also caused a diminution in the ability to mediate adhesion. It is tempting to speculate that the region encompassing the positions of the mutations in these mutants could represent a second cell-binding domain in AIDA-I; however, alternatively, the mutations could indirectly affect the same binding site affected by the mutations in the N-terminal part of the protein. We also observed that bacteria expressing three different mutants, I9, I12, and I13, could adhere to cultured cells as well as bacteria expressing the wild-type protein but were unable to invade the cells. This observation therefore suggests that adhesion and invasion involve different mechanisms. Consistent with this view, but unexpectedly, we observed that invasion mediated by the I4, I23, and I24 mutants was not significantly affected, whereas the ability of these mutants to mediate adhesion was reduced, sometimes dramatically (e.g., mutant I23 [Fig. 2C]).


Figure 3
View larger version (16K):
[in this window]
[in a new window]

 
FIG. 3. Schematic diagram of the insertion mutations in AIDA-I and the related phenotypes: locations and effects of the mutations obtained from linker scanning mutagenesis. The open arrows indicate the insertion mutants without a functional defect, whereas the filled arrows indicate mutants with a defect for one or more functions. The filled box represents the HisG tag at the N terminus of mature AIDA-I.

Only one mutant, I24, with a mutation located in the C-terminal part of mature AIDA-I, was unable to mediate bacterial aggregation, but bacteria expressing this mutant could make biofilm as well as bacteria expressing the wild-type protein (Fig. 2A and 2B). This result suggests that biofilm formation and bacterial aggregation are due to distinct mechanisms, as previously observed with Ag43 (15). Consistent with this view, one mutant with a mutation in the N-terminal part of mature AIDA-I, I9, caused a slight diminution in the ability of bacteria to form biofilms but mediated bacterial aggregation as well as the wild-type protein (Fig. 2A and 2B).

Deletion of a putative cell-binding domain in mature AIDA-I. Five insertion mutants with mutations clustered in the N-terminal third of mature AIDA-I affected the adhesion mediated by the protein, suggesting that there is a cell-binding domain in this region. In order to complement these results, we constructed a mutant with the N-terminal third of mature AIDA-I between residues G54 and A225 deleted (the former residue corresponds to the fourth residue of mature AIDA-I, and the latter residue corresponds to the transposon insertion site in mutant I7 [Fig. 4A]).


Figure 4
View larger version (31K):
[in this window]
[in a new window]

 
FIG. 4. Deletion of putative cell-binding domain in mature AIDA-I. (A) Schematic diagram of the deletion construct, showing plasmids pAngH (WT) and pAngH{Delta}N ({Delta}N). The filled box represents the HisG tag at the N terminus of mature AIDA-I. (B) Whole-cell lysates of bacteria harboring an empty vector (lane –), expressing wild-type AIDA-I (lane WT), or expressing the {Delta}N mutant (lane {Delta}N) were obtained and probed with anti-HisG antibodies, which allowed detection of the proprotein (circles) and mature AIDA-I (arrowheads). All plasmids were transformed in bacteria expressing the Aah glycosyltransferase. (C) Heat extracts of the same cultures were obtained, resolved by SDS-PAGE, and stained with Coomassie blue. (D) Detection of glycosylation, using the digoxigenin glycan detection kit, performed with whole-cell lysates. MW, molecular mass.

The correct expression and biogenesis of the {Delta}N mutant were checked by probing whole-cell lysates with antibodies against the HisG tag. As shown in Fig. 4B, a specific polypeptide with a molecular mass slightly greater than 75 kDa was apparent in proteins extracted from bacteria expressing the {Delta}N mutant, which is consistent with the expected size of the mature {Delta}N mutant (63 kDa) with glycosylation. This hypothesis was confirmed by detection of sugar using a glycan detection kit. The reaction of the {Delta}N mutant with the digoxigenin-hydrazine label was identical to that of the wild-type protein (Fig. 4D). In another study, we identified 16 residues of mature AIDA-I which can be modified by heptose molecules (4a). Only four of these residues are located between G54 and A225. This finding therefore explains the fact that the {Delta}N mutant was still glycosylated. Additionally, we performed heat extraction of bacteria expressing the {Delta}N mutant to verify the correct location of the protein at the cell surface (Fig. 4C). Again, a polypeptide of the expected size was apparent, without any degradation product. These assays showed that the {Delta}N mutant was as well expressed, glycosylated, and stable as the wild-type protein.

To assess the effects of this deletion on the functionality of AIDA-I, the four functional assays performed above were conducted again (Fig. 5). Deletion of the N-terminal third of mature AIDA-I did not affect the ability of the protein to mediate bacterial aggregation or biofilm formation (Fig. 5A and B). This suggests that the regions of AIDA-I involved in biofilm formation and autoaggregation are not located in the N-terminal third of the mature protein. However, the {Delta}N mutant was considerably less able to mediate binding to cultured epithelial cells (Fig. 5C). This is in agreement with the results of the linker scanning mutagenesis analysis that indicated that the ability of mutants I1, I2, I4, I5, and I6 to mediate adhesion was affected. This appears to contradict the hypothesis that there is a secondary cell-binding site. It should be noted, however, that the level of invasion by bacteria expressing the {Delta}N mutant was marginally lower than the level of invasion by bacteria expressing wild-type AIDA-I (Fig. 5D). This result shows that the {Delta}N mutant has a low level of cell-binding ability, consistent with the hypothesis that two regions are important for adhesion. The difference in the extents to which adhesion and invasion are affected is also similar to observations made with the I4, I23, and I24 mutants (Fig. 2C).


Figure 5
View larger version (18K):
[in this window]
[in a new window]

 
FIG. 5. Function of AIDA-I bearing the {Delta}N deletion. An autoaggregation assay (A), a biofilm formation assay (B), an adhesion assay (C), and an invasion assay (D) were performed with cultures of C600 bearing an empty vector (bar –), plasmids pAngH and pAah (bar WT), or plasmids pAngH{Delta}N and pAah (bar {Delta}N). The assays were performed as described in the legend to Fig. 2. NS, not significant.

We constructed three additional mutants with deletions in mature AIDA-I, corresponding to deletions in the C-terminal portion of the repeats (between G224 and A637 or between G224 and A667) or in all the repeats (between Gly54 and A667). These mutants were visibly expressed less than the wild-type protein or the {Delta}N mutant or were not expressed at all (data not shown), suggesting that the biogenesis, the stability at the cell surface, and/or the global conformation of these mutated proteins may have been disturbed. It is therefore likely that the C-terminal repeats of mature AIDA-I play a more important role in the biogenesis or the structural integrity of the protein. Since these defects were likely to influence the functional assays of the mutants, we decided not to test their functions.

N-terminal domain of mature AIDA-I, glycosylated or not glycosylated, is sufficient to mediate binding to cultured epithelial cells. To confirm that the N-terminal third of mature AIDA-I is involved in the adhesion to epithelial cells, we fused this region, corresponding to residues A50 to G224, to GST. Using affinity chromatography, we purified the GST protein alone as a control and the unglycosylated and glycosylated forms of the GST-AIDAN fusion protein by coexpression with or without the Aah glycosyltransferase (Fig. 6A). The GST-AIDAN fusion protein encompasses four glycosylation sites that we identified. The glycosylation status of this protein was confirmed with a glycan detection kit (Fig. 6B). In order to demonstrate the binding properties of the N-terminal third of mature AIDA-I, we developed a cell-based ELISA. As shown in Fig. 6C, unglycosylated and glycosylated GST-AIDAN fusion proteins bound in a saturable manner to the HEp-2 cells with equilibrium dissociation constants of 84 and 72 nM, respectively. By comparison, we observed that whole glycosylated AIDA-I could bind to the cells with a dissociation constant of 3 nM. This value is in agreement with the dissociation constant (2 nM) obtained in another study performed with the mature protein (19). The higher dissociation constants obtained with the fusion proteins (84 and 72 nM, compared to 2 or 3 nM for whole AIDA-I) could have been due to the presence of the GST moiety blocking accessibility to cellular receptors, to the difficulty of purifying a fusion protein as stable as the native protein, or to the possible presence of two binding sites in mature AIDA-I, as suggested by the results of our mutagenesis analysis.


Figure 6
View larger version (41K):
[in this window]
[in a new window]

 
FIG. 6. Cell-binding properties of glycosylated (Glyc.) and unglycosylated (Unglyc.) GST-AIDAN. (A) Coomassie blue-stained SDS-PAGE gel of the purification products from the soluble fraction of strain BL21 bearing plasmid pGex-4T-1, pGex-AIDAN, or pGex-AIDAN and pAah obtained by performing affinity chromatography with a glutathione Sepharose column. The arrowheads indicate the position of the purified protein. (B) Detection of glycosylation of the purified proteins using the digoxigenin glycan detection kit. (C) Cell-based ELISA. HEp-2 cells were grown in a 96-well plate and, after fixation and blocking, were incubated with various concentrations of whole AIDA-I ({blacksquare}), GST (x), unglycosylated GST-AIDAN (•), or glycosylated GST-AIDAN ({circ}). Bound proteins were detected with an antibody against GST or AIDA-I coupled to HRP. The activity of HRP was measured using a colorimetric substrate by monitoring absorption at 450 nm. The background value was subtracted, and the absorption was normalized by dividing the absorption of each well by the maximal absorption measured on the plate in order to obtain percentages of maximal binding. MW, molecular mass.

In order to qualitatively assess the adhesion properties of the N-terminal region of mature AIDA-I and to confirm the results of the cell-based ELISA, we used an immunofluorescence microscopy technique to visualize the binding of unglycosylated or glycosylated GST-AIDAN to live cells using an antibody raised against GST. As shown in Fig. 7, unglycosylated and glycosylated GST-AIDAN bound specifically to live cells in a similar manner, whereas GST alone gave no signal. This result highlights the importance of the N-terminal domain of AIDA-I in adhesion to epithelial cells and suggests that glycosylation is not important in adhesion.


Figure 7
View larger version (71K):
[in this window]
[in a new window]

 
FIG. 7. Immunofluorescence detection of purified unglycosylated (Unglyc.) and glycosylated (Glyc.) GST-AIDAN on the surface of epithelial cells. Purified GST, unglycosylated GST-AIDAN, and glycosylated GST-AIDAN fusion proteins were added to confluent HEp-2 cells at a concentration of 1 µM and incubated at 37°C for 1 h. After binding of the proteins, the cells were washed, fixed, and blocked with bovine serum albumin before detection of bound proteins with antibody raised against GST. Immune complexes were revealed by incubation with a donkey anti-goat immunoglobulin G-rhodamine red conjugate.


arrow
DISCUSSION
 
In this study, we generated 29 different mutants by linker scanning mutagenesis. The positions of the mutants were distributed along the full length of mature AIDA-I. However, as shown in Fig. 8A, 27 of the 29 insertions were located in the first 700 amino acids of the protein, a region of mature AIDA-I consisting of approximately 35 imperfect repeats of a 19-amino-acid sequence shared with the other SAATs (16). By contrast, only two insertions were found in the last 200 amino acids of mature AIDA-I, suggesting that there was a bias against insertions in this part of the protein. Since we did not include the insertions that disrupted protein expression in our study, it is tempting to speculate that the region outside the repeats may be important for the structural integrity of the protein.


Figure 8
View larger version (62K):
[in this window]
[in a new window]

 
FIG. 8. Locations of the five-amino-acid insertions in AIDA-I. (A) Sequence of the N-terminal part of the passenger domain of AIDA-I showing the imperfectly repeated 19-amino-acid motif repeated 35 times. The positions of the insertion mutations are indicated. The circles indicate the positions of the identified glycosylation sites (4a). (B) Weblogo (http://weblogo.berkeley.edu/) representation of the repeated motif, showing the relative conservation of each amino acid of the consensus. Each repeat of this motif is thought to correspond to a coil of a β helix and is predicted to consist of three β strands, as previously modeled (13). The positions of the strands, with the original nomenclature of the model, are indicated. (C) Locations of the five-amino-acid insertions in the coil model. A filled circle represents an isoleucine, valine, or leucine residue, and "X" indicates any residue. The open squares represent insertions that did not affect the functions of AIDA-I. The shaded squares indicate insertions that disrupted one or more of the functions.

The structures of extracellular domains of many autotransporters are thought to consist of a β helix. A recent study proposed structural models for various autotransporter helix coils, which consist of three β strands (13). We used the model proposed for TibA (Fig. 8B), since the consensus sequence of its repeats is identical to that of AIDA-I, in order to map the transposon insertion sites in the AIDA-I mutants on the model (Fig. 8C). Interestingly, almost none of the insertions occurring in the loops connecting the strands affected function. This might have been due to the fact that loops can easily accommodate additional amino acids, compared with strands. The previously described structures of extracellular domains of autotransporters show that the β helices are stabilized by stacked amino acid residues (6, 26). An insertion in a strand might therefore displace a part of the strand either before or after the position of the stacked residues, which would act as an "anchor." The inserted residues would then replace part of the strand and "bulge out" of the β helix. The insertion could additionally have long-distance effects by destabilizing the whole β helix. It is likely, however, that in the latter case the stability of the whole protein would be severely affected. It should be noted that different sequences inserted at the same location, such as the sequences of mutants I8 and I9, resulted in different phenotypes in the assays. Similarly, the I3 mutant had an insertion between amino acids G149 and H150 and behaved like the wild-type strain, whereas the neighboring insertion mutants I2 (L148-G149) and I4 (H150-A151) were deficient for adhesion. These observations suggest that both the inserted sequence and the location of the insertion influence the functionality of the resulting mutant.

As shown in Fig. 8C, the β2 strands seemed to harbor more of the insertions that did not affect function, whereas the β1 strands seemed to be more important for the functionality of the protein, as five of the six insertions in these strands disrupted one or more functions related to the expression of AIDA-I. This observation raises the possibility that the functionality of AIDA-I might be localized predominantly on one of the faces of the β helix. In this respect, we noticed that the mutations affecting adhesion and/or invasion are clustered in β1 strands and, to a lesser extent, in β2 and β3 strands, whereas the mutations that affect biofilm formation or autoaggregation are in β2 strands. This could suggest that the interactions with eukaryotic cells involve primarily the face of the β helix formed by the β1 strands, whereas autoaggregation or biofilm formation requires the face formed by the β2 strands.

The main conclusion of our study is that a cell-binding domain is present in the N-terminal third of mature AIDA-I. First, we identified five different insertions in this N-terminal region that resulted in a deficiency in adhesion to cultured epithelial cells. Second, AIDA-I with a deletion of the amino acids between G54 and A225 was unable to mediate adhesion to HEp-2 cells. Finally, the N-terminal region (between A50 and G224) fused to GST could efficiently bind to epithelial cells, as assessed by a cell-based ELISA and by immunofluorescence microscopy. The fusion protein could bind whether it was glycosylated or not. The observation that glycosylation is not required for binding is in agreement with our recent finding that glycosylation of AIDA-I is required to ensure the normal conformation of the protein and therefore might only indirectly affect the adhesion to epithelial cells (4a). Based on the known structures of other autotransporters (6, 12, 26), the N-terminal location of the primary binding domain of AIDA-I could make the interaction with a host cell receptor easier, as this part of the protein is farther away from the cell surface. The presence of a cell-binding domain at the N-terminal end of a bacterial adhesin has been reported before, for instance in the case of the Yersinia enterocolitica trimeric autotransporter adhesin YadA (28).

We also identified in the C-terminal half of mature AIDA-I three other insertion mutations that resulted in a reduction in the adhesion phenotype. Our results therefore suggest that this protein possesses two binding domains, one in the N-terminal third and one in the C-terminal half. The presence of different binding domains in the same adhesin has been described previously, for instance in trimeric autotransporters such as Haemophilus influenzae Hia (18) and in the E. coli Dr adhesin (17). As mentioned above, we noticed that most insertions affecting adhesion were located in the predicted β1 strands and to a lesser extent in the predicted β3 strands. The two faces of the β helix formed by these strands might therefore harbor the two different binding sites. Alternatively, the insertions in the C-terminal half of the protein could indirectly affect the N-terminal cell-binding domain. For instance, the N and C termini of the repeats might be spatially close in the three-dimensional structure. More work is required to distinguish between these possibilities.

Our results further suggest that invasion and adhesion rely on different mechanisms. Indeed, we identified three insertion mutants, I9, I12, and I13, which mediated binding to epithelial cells as well as the wild-type protein but were unable to mediate invasion. Invasion mediated by AIDA-I is therefore likely not to be just the effect of passive uptake by cultured epithelial cells; rather, it seems to rely on a specific mechanism. Bacteria expressing the I4, I23, and I24 insertion mutants or the {Delta}N deletion mutant exhibit impaired adhesion but only slightly reduced invasion. These results suggest that the binding to a receptor involved in adhesion could be different from the interactions responsible for invasion. Similarly, it was recently observed that variants of the YadA trimeric autotransporter with reduced binding to laminin exhibited greater binding to fibronectin and resulted in an increase in integrin-mediated invasion (8).

Finally, we obtained two mutants (I9 and I24) whose abilities to mediate autoaggregation and biofilm formation were not correlated; a nonaggregative mutant could mediate biofilm formation and vice versa. Separation of these two a priori related phenotypes has also been noted for Ag43 (15). Collectively, these studies therefore support the idea that biofilm formation mediated by AIDA-I involves more than the ability of bacterial cells to interact with one another.

A more precise picture of the AIDA-I autotransporter emerged from our study. Given the similarity that AIDA-I shares with Ag43 and TibA, our results are likely to apply to these and other putative SAAT proteins and shed new light on how these versatile proteins participate in the pathogenesis of diarrheagenic E. coli.


arrow
ACKNOWLEDGMENTS
 
This work was supported by financial contributions from the Groupe de Recherche et d'Etudes sur les Maladies Infectieuses du Porc (GREMIP), the Natural Sciences and Engineering Research Council of Canada (NSERC discovery grant 262746), the Canada Research Chair program, and the Canada Foundation for Innovation (CFI project 201414) and by graduate fellowship FQRNT 114663 to M.-E.C. from the Fonds de Recherche sur la Nature et les Technologies du Québec.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: 3200 Sicotte, Saint-Hyacinthe, Québec, J2S 7C6 Canada. Phone: (450) 773-8521, ext. 18430. Fax: (450) 778-8108. E-mail: m.mourez{at}umontreal.ca Back

{triangledown} Published ahead of print on 12 October 2007. Back

{dagger} Supplemental material for this article may be found at http://jb.asm.org/. Back


arrow
REFERENCES
 
    1
  1. Benz, I., and M. A. Schmidt. 1992. AIDA-I, the adhesin involved in diffuse adherence of the diarrhoeagenic Escherichia coli strain 2787 (O126:H27), is synthesized via a precursor molecule. Mol. Microbiol. 6:1539-1546.[CrossRef][Medline]
  2. 2
  3. Benz, I., and M. A. Schmidt. 1989. Cloning and expression of an adhesin (AIDA-I) involved in diffuse adherence of enteropathogenic Escherichia coli. Infect. Immun. 57:1506-1511.[Abstract/Free Full Text]
  4. 3
  5. Benz, I., and M. A. Schmidt. 2001. Glycosylation with heptose residues mediated by the aah gene product is essential for adherence of the AIDA-I adhesin. Mol. Microbiol. 40:1403-1413.[CrossRef][Medline]
  6. 4
  7. Charbonneau, M. E., F. Berthiaume, and M. Mourez. 2006. Proteolytic processing is not essential for multiple functions of the Escherichia coli autotransporter adhesin involved in diffuse adherence (AIDA-I). J. Bacteriol. 188:8504-8512.[Abstract/Free Full Text]
  8. 4
  9. Charbonneau, M.-E., V. Girard, A. Nikolakakis, M. Campos, F. Berthiaume, F. Dumas, F. Lepine, and M. Mourez. O-linked glycosylation ensures the normal conformation of the autotransporter adhesin involved in diffuse adherence. J. Bacteriol., in press.
  10. 5
  11. Elsinghorst, E. A., and J. A. Weitz. 1994. Epithelial cell invasion and adherence directed by the enterotoxigenic Escherichia coli tib locus is associated with a 104-kilodalton outer membrane protein. Infect. Immun. 62:3463-3471.[Abstract/Free Full Text]
  12. 6
  13. Emsley, P., I. G. Charles, N. F. Fairweather, and N. W. Isaacs. 1996. Structure of Bordetella pertussis virulence factor P.69 pertactin. Nature 381:90-92.[CrossRef][Medline]
  14. 7
  15. Fexby, S., T. Bjarnsholt, P. O. Jensen, V. Roos, N. Hoiby, M. Givskov, and P. Klemm. 2007. Biological Trojan horse: antigen 43 provides specific bacterial uptake and survival in human neutrophils. Infect. Immun. 75:30-34.[Abstract/Free Full Text]
  16. 8
  17. Heise, T., and P. Dersch. 2006. Identification of a domain in Yersinia virulence factor YadA that is crucial for extracellular matrix-specific cell adhesion and uptake. Proc. Natl. Acad. Sci. USA 103:3375-3380.[Abstract/Free Full Text]
  18. 9
  19. Henderson, I. R., M. Meehan, and P. Owen. 1997. Antigen 43, a phase-variable bipartite outer membrane protein, determines colony morphology and autoaggregation in Escherichia coli K-12. FEMS Microbiol. Lett. 149:115-120.[CrossRef][Medline]
  20. 10
  21. Henderson, I. R., and J. P. Nataro. 2001. Virulence functions of autotransporter proteins. Infect. Immun. 69:1231-1243.[Free Full Text]
  22. 11
  23. Henderson, I. R., F. Navarro-Garcia, M. Desvaux, R. C. Fernandez, and D. Ala'Aldeen. 2004. Type V protein secretion pathway: the autotransporter story. Microbiol. Mol. Biol. Rev. 68:692-744.[Abstract/Free Full Text]
  24. 12
  25. Junker, M., C. C. Schuster, A. V. McDonnell, K. A. Sorg, M. C. Finn, B. Berger, and P. L. Clark. 2006. Pertactin beta-helix folding mechanism suggests common themes for the secretion and folding of autotransporter proteins. Proc. Natl. Acad. Sci. USA 103:4918-4923.[Abstract/Free Full Text]
  26. 13
  27. Kajava, A. V., and A. C. Steven. 2006. The turn of the screw: variations of the abundant beta-solenoid motif in passenger domains of type V secretory proteins. J. Struct. Biol. 155:306-315.[CrossRef][Medline]
  28. 14
  29. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140.[CrossRef][Medline]
  30. 15
  31. Klemm, P., L. Hjerrild, M. Gjermansen, and M. A. Schembri. 2004. Structure-function analysis of the self-recognizing antigen 43 autotransporter protein from Escherichia coli. Mol. Microbiol. 51:283-296.[CrossRef][Medline]
  32. 16
  33. Klemm, P., R. M. Vejborg, and O. Sherlock. 2006. Self-associating autotransporters, SAATs: functional and structural similarities. Int. J. Med. Microbiol. 296:187-195.[CrossRef][Medline]
  34. 17
  35. Korotkova, N., E. Cota, Y. Lebedin, S. Monpouet, J. Guignot, A. L. Servin, S. Matthews, and S. L. Moseley. 2006. A subfamily of Dr adhesins of Escherichia coli bind independently to decay-accelerating factor and the N-domain of carcinoembryonic antigen. J. Biol. Chem. 281:29120-29130.[Abstract/Free Full Text]
  36. 18
  37. Laarmann, S., D. Cutter, T. Juehne, S. J. Barenkamp, and J. W. St. Geme. 2002. The Haemophilus influenzae Hia autotransporter harbours two adhesive pockets that reside in the passenger domain and recognize the same host cell receptor. Mol. Microbiol. 46:731-743.[CrossRef][Medline]
  38. 19
  39. Laarmann, S., and M. A. Schmidt. 2003. The Escherichia coli AIDA autotransporter adhesin recognizes an integral membrane glycoprotein as receptor. Microbiology 149:1871-1882.[Abstract/Free Full Text]
  40. 20
  41. Lindenthal, C., and E. A. Elsinghorst. 1999. Identification of a glycoprotein produced by enterotoxigenic Escherichia coli. Infect. Immun. 67:4084-4091.[Abstract/Free Full Text]
  42. 21
  43. Mainil, J. G., E. Jacquemin, P. Pohl, A. Kaeckenbeeck, and I. Benz. 2002. DNA sequences coding for the F18 fimbriae and AIDA adhesin are localised on the same plasmid in Escherichia coli isolates from piglets. Vet. Microbiol. 86:303-311.[CrossRef][Medline]
  44. 22
  45. Moormann, C., I. Benz, and M. A. Schmidt. 2002. Functional substitution of the TibC protein of enterotoxigenic Escherichia coli strains for the autotransporter adhesin heptosyltransferase of the AIDA system. Infect. Immun. 70:2264-2270.[Abstract/Free Full Text]
  46. 23
  47. Nataro, J. P., I. C. Scaletsky, J. B. Kaper, M. M. Levine, and L. R. Trabulsi. 1985. Plasmid-mediated factors conferring diffuse and localized adherence of enteropathogenic Escherichia coli. Infect. Immun. 48:378-383.[Abstract/Free Full Text]
  48. 24
  49. Ngeleka, M. 2002. Isolation of a new Escherichia coli pathotype associated with diarrhea in piglets. Can. Vet. J. 43:623-624.[Medline]
  50. 25
  51. Niewerth, U., A. Frey, T. Voss, C. Le Bouguenec, G. Baljer, S. Franke, and M. A. Schmidt. 2001. The AIDA autotransporter system is associated with F18 and stx2e in Escherichia coli isolates from pigs diagnosed with edema disease and postweaning diarrhea. Clin. Diagn. Lab. Immunol. 8:143-149.[CrossRef][Medline]
  52. 26
  53. Otto, B. R., R. Sijbrandi, J. Luirink, B. Oudega, J. G. Heddle, K. Mizutani, S. Y. Park, and J. R. Tame. 2005. Crystal structure of hemoglobin protease, a heme binding autotransporter protein from pathogenic Escherichia coli. J. Biol. Chem. 280:17339-17345.[Abstract/Free Full Text]
  54. 27
  55. Owen, P., P. Caffrey, and L. G. Josefsson. 1987. Identification and partial characterization of a novel bipartite protein antigen associated with the outer membrane of Escherichia coli. J. Bacteriol. 169:3770-3777.[Abstract/Free Full Text]
  56. 28
  57. Roggenkamp, A., K. Ruckdeschel, L. Leitritz, R. Schmitt, and J. Heesemann. 1996. Deletion of amino acids 29 to 81 in adhesion protein YadA of Yersinia enterocolitica serotype O:8 results in selective abrogation of adherence to neutrophils. Infect. Immun. 64:2506-2514.[Abstract]
  58. 29
  59. Scaletsky, I. C., M. L. Silva, and L. R. Trabulsi. 1984. Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells. Infect. Immun. 45:534-536.[Abstract/Free Full Text]
  60. 30
  61. Servin, A. L. 2005. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin. Microbiol. Rev. 18:264-292.[Abstract/Free Full Text]
  62. 31
  63. Sherlock, O., U. Dobrindt, J. B. Jensen, R. Munk Vejborg, and P. Klemm. 2006. Glycosylation of the self-recognizing Escherichia coli Ag43 autotransporter protein. J. Bacteriol. 188:1798-1807.[Abstract/Free Full Text]
  64. 32
  65. Sherlock, O., M. A. Schembri, A. Reisner, and P. Klemm. 2004. Novel roles for the AIDA adhesin from diarrheagenic Escherichia coli: cell aggregation and biofilm formation. J. Bacteriol. 186:8058-8065.[Abstract/Free Full Text]
  66. 33
  67. Sherlock, O., R. M. Vejborg, and P. Klemm. 2005. The TibA adhesin/invasin from enterotoxigenic Escherichia coli is self recognizing and induces bacterial aggregation and biofilm formation. Infect. Immun. 73:1954-1963.[Abstract/Free Full Text]
  68. 34
  69. Suhr, M., I. Benz, and M. A. Schmidt. 1996. Processing of the AIDA-I precursor: removal of AIDAc and evidence for the outer membrane anchoring as a beta-barrel structure. Mol. Microbiol. 22:31-42.[CrossRef][Medline]


Journal of Bacteriology, December 2007, p. 9020-9029, Vol. 189, No. 24
0021-9193/07/$08.00+0     doi:10.1128/JB.01238-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Charbonneau, M.-E., Janvore, J., Mourez, M. (2009). Autoprocessing of the Escherichia coli AIDA-I Autotransporter: A NEW MECHANISM INVOLVING ACIDIC RESIDUES IN THE JUNCTION REGION. J. Biol. Chem. 284: 17340-17351 [Abstract] [Full Text]  
  • May, K. L., Morona, R. (2008). Mutagenesis of the Shigella flexneri Autotransporter IcsA Reveals Novel Functional Regions Involved in IcsA Biogenesis and Recruitment of Host Neural Wiscott-Aldrich Syndrome Protein. J. Bacteriol. 190: 4666-4676 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Charbonneau, M.-E.
Right arrow Articles by Mourez, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Charbonneau, M.-E.
Right arrow Articles by Mourez, M.